Betamethosone causes, "an immature fetus's lungs to produce a compound called surfactant. A full-term baby's lungs naturally produce surfactant, which lubricates the lining of the air sacs within the lungs. This allows the inner surfaces of the air sacs to slide against one another without sticking during breathing. Premature infants whose lungs have begun producing surfactant are more able to breathe on their own, or with less respiratory treatment, after birth" (webmd.com). Basically, this shot will "benefit a premature newborn by lowering the risk of:
- Breathing problems (respiratory distress syndrome) after birth.
- Bleeding in the brain (intraventricular hemorrhage).
- Intestinal infection (necrotizing enterocolitis).
- Death" (webmd.com).